44 results about "Intravenous use" patented technology

The invention provides an infusion warning indicator, and belongs to the technical field of infusion warning. Comprising a fixing frame, one side of the top of the fixing frame is fixedly connected with a first supporting frame, an infusion tube is installed at the top of the fixing frame, an infusion needle is installed at the end of the infusion tube, and an alarm body is installed on the infusion tube; and the limiting and guiding mechanism is used for fixing the infusion needle and guiding puncture. Through cooperative use of the limiting guide mechanism and the locking mechanism, the alarm body gives out alarm sound to remind a patient when detecting whether infusion of drip liquid is finished or not, and the patient can quickly press and operate the locking mechanism to lock an infusion tube at the moment and then wait for medical staff to change medicine or withdraw a needle; the problem that blood flows back or air enters during the period of waiting for medical staff is effectively prevented, and the limiting guide mechanism can well assist the medical staff in infusion and needle insertion, so that needle insertion operation is facilitated.

1. Name of the product in this design: Intravenous drip sensor (rechargeable). 2. Purpose of this design: For use as a vein drip sensor. 3. The key design elements of this product are the combination of shape, pattern, and color. 4. The image or photograph that best illustrates the design's key points: a 3D model. 5. The design for which protection is sought includes color.

1. The name of the product of this design: IV stand (emergency department nursing). 2. Purpose of the product with this appearance design: The product with this appearance design is used for giving intravenous drips to patients in the emergency department. 3. The design key point of this appearance design product lies in the shape. 4. The picture or photo that best illustrates the design points: three-dimensional picture.

The present invention is a Miniature Vein Enhancer that includes a Miniature Projection Head. The Miniature Projection Head may be operated in one of three modes, AFM, DBM, and RTM. The Miniature Projection Head of the present invention projects an image of the veins of a patient, which aids the practitioner in pinpointing a vein for an intravenous drip, blood test, and the like. The Miniature projection head may have a cavity for a power source or it may have a power source located in a body portion of the Miniature Vein Enhancer. The Miniature Vein Enhancer may be attached to one of several improved needle protectors, or the Miniature Vein Enhancer may be attached to a body similar to a flashlight for hand held use. The Miniature Vein Enhancer of the present invention may also be attached to a magnifying glass, a flat panel display, and the like.

To provide a therapeutic and / or prophylactic agent for mycosis, which is excellent in safety and effectiveness, is administered to a Japanese mycosis patient, and contains isavuconazole or a prodrug thereof as an active ingredient.SOLUTION: A therapeutic and / or prophylactic agent for mycosis, which is administered according to a loading dosing regimen, and further administered according to a maintenance dosing regimen after a lapse of 12 to 24 hours from the end of the loading dosing regimen. (1) Loading dosing schedule: a dosing schedule in which isavuconazole or a pro-drug thereof is administered in 200mg by oral administration or intravenous drip infusion every 8 hours for a total of 6 times (2) Maintenance dosing schedule: a dosing schedule in which isavuconazole or a pro-drug thereof is administered in 200mg by oral administration or intravenous drip infusion once a day in terms of isavuconazole per dose.SELECTED DRAWING: Figure 1

The article to which this design pertains is an arm cover. This article (arm cover) is used to prevent hospitalized patients from removing their intravenous drips.

The utility model discloses an outdoor outpatient service trolley, and belongs to the technical field of trolleys. Comprising a trolley carrying plate, a protection frame is arranged at the top end of the trolley carrying plate and used for protecting a child, an adjusting mechanism is arranged on one side of the top end of the trolley carrying plate and used for adjusting the use height of an infusion bottle frame, and a locking assembly is arranged on one side of a second side plate and used for locking the infusion bottle frame. The locking assembly is used for locking the height of the adjusted infusion bottle frame, through the arrangement of the adjusting mechanism and the protection frame, the protection frame can provide a lying space for a child, the child can have a rest for infusion conveniently, the adjusting mechanism can adjust the height of an infusion bottle, the infusion bottle can be better placed conveniently, the adjusting mechanism can be folded when the infusion bottle frame is not used, and use of the trolley is not affected.

The disclosure is directed to an aseptic, ready-to-use, premixed liquid pharmaceutical composition having sodium bicarbonate in a concentration of from about 0.05 mEq / mL to about 5 mEq / mL, carbon dioxide, and optionally one or more pharmaceutically acceptable excipients, the liquid pharmaceutical composition being packaged in a container for intravenous use, and the container including polyethylene terephthalate and SiOx. Also disclosed are method of making the an aseptic, ready-to-use, premixed liquid pharmaceutical compositions described herein.

The invention relates to the technical field of traditional Chinese medicines, and particularly discloses a navel therapy composition and a navel therapy preparation for preventing and treating abdominal pain caused by intravenous drip of azithromycin in children and a preparation method of the navel therapy composition and the navel therapy preparation. The technical key points are as follows: the fructus evodiae and the dysentery are combined according to a specific weight ratio, and are matched with pharmaceutic adjuvants such as a transdermal enhancer and an excipient to prepare special navel therapy dosage forms such as pills, cakes, patches and the like. According to the composition, by utilizing the characteristics that the Shenque acupoint (navel) epidermal cuticle is thin, the barrier function is weak, blood vessels are rich, and medicines are easy to disperse and absorb, adverse reactions such as gastrointestinal spasmodic pain, nausea and vomiting and the like caused by intravenous drip of azithromycin in children are effectively relieved through an administration mode of external application. Through clinical verification, the umbilical therapy preparation can remarkably reduce the incidence rate and severity score of stomachache, vomiting and diarrhea, and remarkably improve the treatment compliance of child patients.

To provide a program that outputs symptom information regarding signs of self-removal of intravenous drip. [Solution] The program acquires time-series data regarding the movement of a second hand, different from the first hand being punctured, and outputs symptom information by inputting the acquired time-series data into a learning model that outputs symptom information regarding signs of self-removal of an IV drip when time-series data is input. Preferably, the program acquires video data of the puncture site and the movement of the second hand captured by a camera, and inputs the video data into the learning model to output the symptom information.

To provide improved, stable aspirin formulations for intravenous use, as well as applications thereof.SOLUTION: A lyophilized aspirin composition is provided, the composition comprising a lyophilized mixture of crystalline aspirin in the free acid form, a bulking agent, and a surfactant. Also provided is the use of the lyophilized aspirin composition in the manufacture of a medicament for aspirin therapy by intravenous administration to a mammal in need thereof, the manufacture comprising reconstituting the lyophilized aspirin composition with water comprising a basic agent in an amount sufficient to provide an aspirin solution having a pH of at least 5.5.SELECTED DRAWING: None

The invention belongs to the field of medicines, and provides a letemovir injection and a preparation method thereof, the letemovir injection is a high-concentration letemovir injection for intravenous drip, and the letemovir injection comprises letemovir, an alkaline reagent, a pH regulator, a buffer agent, a non-aqueous solvent for injection and water for injection. According to the injection, the solubility of letemovir is greatly improved, hydroxypropyl-beta-cyclodextrin is abandoned as a solubilizer in a prescription, so that accumulated toxicity of the kidney is avoided, and the injection prescription does not contain other known solubilizers and surfactants for pharmaceutical preparations, so that the medication safety is remarkably improved; the injection can tolerate thermocompression sterilization, no visible foreign matter exists in the sterilized solution and after compatibility, the adverse reaction risk caused by capillary obstruction is avoided or reduced, and the clinical medication safety is remarkably improved; the preparation process is simple, production amplification is easy to realize, and the method has great application value.

To provide an injection solution for boron neutron capture therapy.SOLUTION: Provided is an injection solution for boron neutron capture therapy, containing p-boronophenylalanine with a boron-10 content that constitutes 75% or more of the boron atoms in the compound or a pharmaceutically acceptable salt thereof; a sugar alcohol; an antioxidant; a citric acid; and water, the injection solution having a pH of 6.5 to 7.5 and an osmotic pressure ratio of 1.0 to 1.8, the injection solution configured to be administered by intravenous drip injection.SELECTED DRAWING: None

The present invention relates to a stable antibody formulation for intravenous use comprising: a. about 10-40 mg / mL nivolumab, b. about 20 mM L-histidine buffer, c. about 270 mM sucrose, d. about 0.02 % w / v polysorbate 80, and e. about 10 mM L-methionine. The antibody formulation is stable at about 2 °C to about 8 °C for about 12 months. The stable antibody formulation is for use in the treatment of cancer.

To provide a simple retainer that can retain a plurality of infusion tubes to a support body around a bed while juxtaposing the infusion tubes without any tangle.SOLUTION: A retainer 1 includes: a substrate 2 made of a substantially rectangular solid-shaped foam plastic; a reinforcement member 3 made of an elastic synthetic resin and fitted into the substrate and fixed to the substrate; and a fixing member 4 for holding the substrate 2 to a support body around a bed. The substrate 2 is made of a foam plastic and includes: a plurality of slits 21 for nipping an infusion tube 103; a plurality of guide grooves 22 for guiding insertion of the infusion tube 103 into the slit 21; a plurality of nipping parts 23 for elastically nipping the infusion tube 103 between both sides of the slit 21; and a notch 24 for fitting the reinforcement member 3. The fixing member 4 comprises first and second hook-and-loop fasteners 41, 42.SELECTED DRAWING: Figure 2

The item in question is an armrest that is standard equipment on stretchers used in hospitals and ambulances for transporting patients. The armrest is usually positioned vertically to narrow the width of the stretcher for transporting patients, but in some cases, blood transfusions and intravenous drips are administered. The armrest is opened horizontally, allowing the patient's arm to rest on the top surface. However, when the armrest on a typical stretcher is opened, the top surface is significantly lower than the mat, causing the patient's arm to hang at an angle, making intravenous drips difficult to administer. This armrest has a double structure with an upper and lower panel overlapping each other. Two fixing pins on the lower panel are inserted into the stretcher's pivot bosses to secure the armrest in place. Furthermore, when a lever located in the gap between the upper and lower panels is rotated, the upper panel rises significantly via a link. The lever rotates in an arc, and as can be seen in the plan view, the lever grip does not protrude outward at either the right or left extreme positions. When the lever is set to the right end, the arm rest becomes thinner, while when set to the left end, the top panel rises and becomes thicker, making IV administration easier. During normal transport, the arm rest is kept thin and vertically positioned so that it does not protrude to the side, resulting in no inconvenience. When an urgent transfusion or IV is required, the top panel of the arm rest rises with a single touch, saving time and allowing for quick preparation, a major advantage. While it is possible to place a cushion under the arm, the interior of an ambulance is often too narrow to store a cushion, and it can easily get lost. Having this arm rest as standard equipment eliminates this problem. Since transfusions and IVs are usually administered in the right arm, this arm rest only needs to be standard equipment on the right side.

This product is a hollow, tubular tourniquet that is worn around the arm during blood collection, intravenous drips, etc., and has a flower-shaped cavity formed continuously in the longitudinal direction in the radial center. The cross section of the cavity is shaped like a flower, giving it a playful touch, and can help relieve tension for the user during blood collection, intravenous drips, etc.

The utility model relates to an equipment belt structure for an assembled ward. The equipment belt structure comprises a mounting unit, a main body unit, a locking unit, a hook unit and an adjusting unit, the connecting structure has the advantages that after the mounting unit is connected with the wall body, the mounting unit is connected with the main body unit in a clamping mode, traditional punching bolt fixing is replaced, damage to a prefabricated wall body structure is avoided, the integrity of the wall body and the advantages of a fabricated building are reserved, meanwhile, the mounting process is simplified, and the construction efficiency is improved; movement of the main body unit can be limited by the locking unit, loosening and displacement of the equipment belt caused by external force collision are avoided, and use safety is guaranteed. The hook unit is matched with the adjusting unit, so that the limitation that the hanging position of an infusion bottle is fixed is solved. The adjusting unit can flexibly adjust the transverse position of the hook unit according to the actual requirements of patients and the position change of the sickbed, the infusion requirements of different patients are met, and operation of medical staff is facilitated.

An infusion device for generating ozone liquid, which is composed of a gas-liquid mixing tube, an air inlet tube, a liquid inlet tube, a liquid storage bag, an exhaust pipe, a liquid discharge pipe, a drip bucket, a flow regulator, a puncture device, and an injection needle fixed on a pipeline plate; Based on the existing intravenous drip technology, the present invention introduces medical ozone gas to achieve the simultaneous generation of ozone liquid and intravenous drip of ozone liquid, which is significantly superior to the existing intravenous injection technology of ozone liquid.

The utility model relates to the field of ultrasonic machine intravenous drip hanging racks, in particular to an ultrasonic machine with a folding intravenous drip hanging rack, which at least comprises a base component, and the base component has a sliding storage function and a rotating locking function. And the extension assembly has a dual telescopic function, has a very long sliding distance, and can be retracted into the base assembly when being not used while being adjusted to a specified position. According to the ultrasonic machine with the folding intravenous infusion hanging frame, the support can be contained in the machine body through multiple sliding, so that the storage space can be reduced, when an infusion bottle is hung on the support, the support drives the infusion bottle to move together with the machine body, the situation that the infusion bottle is separated from the machine body is avoided, the machine body can be fixed through the suction cup, and the operation is convenient. And displacement is prevented when the point bottle is pulled.

The embodiment of the invention provides an intelligent drug delivery system. The intelligent drug delivery system comprises an MCU control unit, a motor, a drug release pump, a drug storage device and a central venous pressure measuring device. The motor is electrically connected with the MCU control unit, and the output end of the motor is connected with the drug release pump; the liquid medicine input end of the medicine release pump is communicated with the medicine storage device, and the liquid medicine output end of the medicine release pump is communicated with an intravenous injection catheter for intravenous drip of a patient; the signal output end of the central venous pressure measuring device is electrically connected with the MCU through the pressure transmitter. According to the technical scheme, the central venous pressure of a patient is obtained in real time and fed back to the MCU control unit, when the measured value reaches the preset value, the MCU control unit sends a signal to the motor so as to drive the drug release pump to be started and send out a preset amount of drug, and therefore automatic drug delivery is achieved. According to the technical scheme, the dosing opportunity is more accurate, the health of a patient is better facilitated, and meanwhile the working intensity of medical staff is relieved.

The application discloses a kind of oral sustained-release composition of edaravone, preparation method and application.The application provides a kind of pharmaceutical composition, it includes tablet core and coating;The tablet core includes drug-containing layer tablet core and / or boost layer tablet core;The drug-containing layer tablet core includes edaravone pharmaceutical active ingredient and carrier;The carrier is one or more in polymer carrier, osmotic pressure regulator, swelling agent, thickening agent and lubricant;The boost layer tablet core includes one or more in osmotic pressure regulator, swelling agent, colorant and lubricant.The pharmaceutical composition of the application maintains 24 hours sustained-release, oral convenient, blood drug concentration is stable, avoids the method of 2 times intravenous drip in a day, improves patient compliance.In addition, the pharmaceutical composition, prescription and preparation process are simple, easy to industrial production.

The invention discloses an application of a pharmaceutical composition in preparation of a medicine for promoting blood circulation to remove blood stasis, and relates to the technical field of traditional Chinese medicine compound preparations, the pharmaceutical composition comprises the following seven components: a Xuesaitong injection, a ginkgo dipyridamole injection, a salvia miltiorrhiza injection, an astragalus membranaceus injection, a blood pricking and bloodletting device, a Xiaoyao pill oral preparation and a pulse-activating decoction oral liquid; the application method comprises the following steps: sequentially carrying out intravenous drip injection of the Xuesaitong injection, the Ginkgo damole injection and intravenous drip of the Salvia miltiorrhiza injection; then a blood pricking and bloodletting device is used for cooperating operation; and then, carrying out intravenous drip of the astragalus membranaceus injection for administration. After injection, the Xiaoyao pills and the pulse-activating decoction are orally taken; through intravenous injection, blood pricking therapy and oral consolidated drug action paths, a new application way of the pharmaceutical composition in the blood circulation promoting and blood stasis removing drugs is provided, clear sequential use of the blood circulation promoting and blood stasis removing pharmaceutical composition is achieved, the purposes of rapid blood circulation promoting and blood stasis removing and long-acting physique conditioning of the pharmaceutical composition are achieved, and the pharmaceutical composition is safe and efficient.

The disclosed invention relates to a wearable intravenous drip device comprising: a first plate; at least one static load spring mounted on the first plate; a second plate to which a free end of a leaf spring wound around a drum of the static load spring is fixed, and which is disposed to face the first plate; and an upper arm loading part coupled to the second plate, wherein the static load springs apply elastic force causing a relative extension / contraction movement to be generated with respect to the first plate and the second plate, and the elastic force of the static load springs is constant regardless of the displacement of the leaf spring.

The article to which this design pertains is an arm cover. This article (arm cover) is used to prevent hospitalized patients from removing their intravenous drips.

The invention provides a pharmaceutical composition for improving diabetic peripheral neuropathy. The pharmaceutical composition is prepared by the following steps: preparing two groups of pharmaceutical compositions and selecting mice suffering from diabetes mellitus of the same type; the preparation method of the pharmaceutical composition comprises the following steps: adding 100mL of sodium chloride solution into 1mg of mecobalamin injection, carrying out intravenous drip, and carrying out intramuscular injection by adopting 40U of pancreatic kininogenase injection; the preparation method of the pharmaceutical composition comprises the following steps: adding 0.45 g of alpha-lipoic acid into 100 mL of a sodium chloride solution, and carrying out intravenous drip; the method comprises the following steps: selecting 53 mice with diabetes mellitus of the same type, and dividing the 53 mice into a research group and a control group; the clinical treatment effect, the adverse reaction occurrence rate and the sensory motor nerve conduction speed after treatment of the pharmaceutical composition used in a research group are obviously superior to those of a control group; the pharmaceutical composition used by the research group can block the neuropathy of diabetes mellitus through various ways and weaken the oxidation reaction of the disease, so that the nerve impulse conduction is accelerated, neuropeptides, nerve factors and the like are promoted to return to normal, and a good treatment effect is achieved.

To provide a method for preventing precipitation caused by the storage of an injection solution for boron neutron capture therapy.SOLUTION: The present invention provides a method for preventing precipitation of an injection solution for boron neutron capture therapy, the injection solution containing: p-boronophenylalanine or a pharmaceutically acceptable salt thereof; a sugar alcohol; and a pH adjusting agent, having a pH of 6.5 to 8.0 and an osmotic pressure ratio of 1.0 to 1.8, and being to be administered by intravenous drip injection.SELECTED DRAWING: None

This product is a hollow, tubular tourniquet that is worn around the arm during blood collection, intravenous drips, etc., and has a flower-shaped cavity formed continuously in the longitudinal direction in the radial center. The cross section of the cavity is shaped like a flower, giving it a playful touch, and can help relieve tension for the user during blood collection, intravenous drips, etc.

This product is a hollow, tubular tourniquet that is worn around the arm during blood collection, intravenous drips, etc., and has a cavity in the shape of an animal running continuously along the length of the radial center. The cross section of the cavity is shaped like an animal, giving it a playful touch, and it can help relieve tension for the user during blood collection, intravenous drips, etc.